PURPOSE: To determine characteristics and final visual and surgical outcomes of @entity1 who experienced early onset @entity86 after @entity231 surgery and their early and late complications. METHODS: This is a prospective case series of 126 @entity1 out of 1500 cases who underwent @entity231 surgery and experienced early onset @entity86 during the first 2 weeks after @entity231 surgery. All the @entity1 received complete ocular examinations at onset of signs and symptoms of @entity32 . A total of 110 @entity1 with follow-up examinations between 3 and 30 months after recovery of early onset @entity86 (mean follow-up 11.6 months) were enrolled in the next part of the study to evaluate the final visual and surgical outcomes. Background systemic and @entity2194 , type of surgery, type of intraocular lenses and viscoelastic agent, early and late complications, and final best-corrected visual acuity were studied. RESULTS: Among 1500 @entity1 , 126 cases (8.4%) had early onset @entity86 , 64 cases (50.7%) were male, and 62 cases (49.3%) were female. Early complications were posterior @entity5862 in 9 cases (7.1%), @entity616 in 2 cases (1.5%), and acute rise of intraocular pressure in 6 cases (4.7%). Late complications consisted of posterior capsular opacity in 38 cases (34.5%) and @entity1103 in 4 cases (3.2%). Peak of signs and symptoms of @entity32 was during 2 weeks after surgery and all @entity1 responded well to topical @entity230 . Final best-corrected visual acuity (BCVA) was 20/30 and better in 76 cases (69%), between 20/40 and 20/80 in 24 cases (22%), and less than 20/80 in 10 cases (9%). All cases with BCVA less than 20/80 had @entity2194 like @entity1940 scar or age-related @entity1020 , advanced @entity726 , or @entity5575 . CONCLUSIONS: Early onset @entity86 causes @entity158 , @entity227 , and @entity1 @entity148 in the acute phase but neither decreases final visual acuity nor has any significant or permanent ocular sequels.

Outcomes of acute postoperative inflammation after XXXX surgery.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity32 :: ('MESH:D007249', 'Disease') :: ['inflammation'] @entity2194 :: ('MESH:D005128', 'Disease') :: ['ocular diseases'] @entity227 :: ('MESH:D014786', 'Disease') :: ['decreased vision'] @entity1940 :: ('MESH:D020256', 'Disease') :: ['choroidal neovascularization'] @entity231 :: ('MESH:D002386', 'Disease') :: ['cataract'] @entity5575 :: ('MESH:D003318', 'Disease') :: ['corneal opacity'] @entity726 :: ('MESH:D005901', 'Disease') :: ['glaucoma'] @entity1103 :: ('MESH:D008269', 'Disease') :: ['cystoid macular edema'] @entity148 :: ('MESH:D001008', 'Disease') :: ['anxiety'] @entity86 :: ('MESH:D019106', 'Disease') :: ['postoperative inflammation'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity5862 :: ('MESH:D006175', 'Disease') :: ['synechia'] @entity230 :: ('MESH:D013256', 'Chemical') :: ['steroids'] @entity1020 :: ('MESH:D008268', 'Disease') :: ['macular degeneration'] @entity616 :: ('MESH:D006327', 'Disease') :: ['pupillary block']
@entity231 :: (MESH:D002386,Disease) :: ['cataract']
